Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
171 hedge funds and large institutions have $465M invested in Avid Bioservices, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 56 reducing their positions, and 19 closing their positions.
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
11% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 56
6% more capital invested
Capital invested by funds: $437M → $465M (+$27.8M)
3% more funds holding
Funds holding: 166 → 171 (+5)
76% less call options, than puts
Call options by funds: $313K | Put options by funds: $1.3M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Coliseum Capital Management
Rowayton,
Connecticut
|
+$13.4M |
| 2 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$7.53M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$7.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.92M |
| 5 |
1WCM
12 West Capital Management
New York
|
+$6.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$19.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.3M |
| 3 |
NM
Newtyn Management
New York
|
-$10.1M |
| 4 |
Morgan Stanley
New York
|
-$6.07M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.71M |
CDMO Hedge Fund Activity: Q2 2024 in Review
171 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2024, worth a combined $465M — up 6.4% from $437M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new CDMO positions and 19 closed out — a net gain of 6 holders — while 62 added to existing stakes and 56 trimmed.
The largest buyer was Coliseum Capital Management, opening a new position worth an estimated $13.4M. The largest seller was State Street, cutting an estimated $19.2M.
- 171 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2024, up from 166 in Q1 2024.
- Funds reported $465M of Avid Bioservices, Inc. Common Stock stock for Q2 2024, up 6.4% quarter-over-quarter.
- 25 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2024 and 19 closed out, a net change of +6 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2024 was Coliseum Capital Management, an estimated $13.4M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2024 was State Street, an estimated $19.2M sold.
Based on aggregated 13F filings for Q2 2024.